Effect of PSC 833 on the cytotoxicity and pharmacodynamics of mitoxantrone in multidrug-resistant K562 cells. (Q54057394)

24 May 2018

title

Effect of PSC 833 on the cytotoxicity and pharmacodynamics of mitoxantrone in multidrug-resistant K562 cells. (English)

1 reference

24 May 2018

main subject

cytotoxicity

0 references

multiple drug resistance

1 reference

1 reference

T Fukushima

1

1 reference

24 May 2018

T Yamashita

2

1 reference

24 May 2018

H Takemura

3

1 reference

24 May 2018

H Suto

4

1 reference

24 May 2018

S Kishi

5

1 reference

24 May 2018

Y Urasaki

6

1 reference

24 May 2018

T Ueda

7

1 reference

24 May 2018

publication date

1 March 2000

1 reference

24 May 2018

published in

Leukemia Research

1 reference

24 May 2018

volume

24

1 reference

24 May 2018

issue

3

1 reference

24 May 2018

page(s)

249-254

1 reference

24 May 2018

Mechanisms of multidrug resistance and implications for therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900177-0

7 January 2021

MDR1 gene expression and treatment outcome in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900177-0

7 January 2021

Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900177-0

7 January 2021

Cyclosporins as drug resistance modifiers

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900177-0

7 January 2021

Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900177-0

7 January 2021

Reversal of typical multidrug resistance by cyclosporin and its non-immunosuppressive analogue SDZ PSC 833 in Chinese hamster ovary cells expressing the mdr1 phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900177-0

7 January 2021

Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900177-0

7 January 2021

Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900177-0

7 January 2021

Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900177-0

7 January 2021

Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinones

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900177-0

7 January 2021

Mitoxantrone: a new anticancer drug with significant clinical activity

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900177-0

7 January 2021

A clinical and pharmacokinetic study of mitoxantrone in acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900177-0

7 January 2021

DNA topoisomerase poisons as antitumor drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900177-0

7 January 2021

Effect of PSC 833 on the cytotoxicity of idarubicin and idarubicinol in multidrug-resistant K562 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900177-0

7 January 2021

Potentiation of the reversal activity of SDZ PSC833 on multi-drug resistance by an anti-P-glycoprotein monoclonal antibody MRK-16

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900177-0

7 January 2021

10.1016/S0145-2126(99)00177-0

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018